Cardiovascular system in offsprings of hypertensive rats with defective nitric oxide production

Physiological Research

Volumn 51, Issue 5, 2002, Pages 465-474

  Gerova M ^a   Bernatova I ^b   Torok J ^b   Jurani M ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b NONE

Author keywords

Cardiac development; Hypertension; Nitric oxide; Offsprings; Ornithine decarboxylase

Indexed keywords

ACETYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART DEVELOPMENT; HEART RATE; HEART WEIGHT; HYPERTENSION; HYPOTROPHY; MALE; NEWBORN; NONHUMAN; PROGENY; RAT; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; ENZYME INHIBITORS; FEMALE; HEART; HEART RATE; HYPERTENSION; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED WKY; VASODILATOR AGENTS;

EID: 0036959877     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ABMAN SH, CATHFIELD BA, RODMAN DM, HALL SL, MCMURTRY IF: Maturation-related changes in endothelium-dependent relaxation of ovine pulmonary arteries. Am J Physiol 260: L280-L285, 1991.
2. ARNAL JF, AMRANI AI, CHATELLIER G, MENARD J, MICHEL JP: Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
3. BANTING JD, THOMPSON KE, FRIBERG P, ADAMS MA: Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade. Hypertension 30: 416-421, 1997.
4. BARTOLOMÉ J, HUGUENARD J, SLOTKIN TA: Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 210: 793-794, 1980.
5. G-nitro-L-arginine methyl ester-induced hypertension. Circulation 101: 423-429, 2000.
6. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy development without affecting NO synthase activity in rats. Physiol Res 45: 311-316, 1996.
7. BOUCHER JL, MOALI C, TENU JP: Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 55: 1015-1028, 1999.
8. BREDT DS, SNYDER SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
9. CYNOBER L, LE BOUCHER J, VASSON MP: Arginine metabolism in mammals. Nutr Biochem 6: 402-413, 1995.
10. DE OLIVEIRA CF, CINTRA KA, TEIXEIRA SA, DE LUCA IMS, ANTUNES E, DE NUCCI G: Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. Eur J Pharmacol 391: 121-126, 2000.
11. DOMINICZAK AF, BOHR DF: Nitric oxide and its putative role in hypertension. Hypertension 25: 1202-1211, 1995.
12. EL DWAIRI Q, GUO Y, COMTOIS A, ZHU E, GREENWOOD MT, BREDT DS, HUSSAIN SN: Ontogenesis of nitric oxide synthases in the ventilatory muscles. Am J Respir Cell Mol Biol 18: 844-852, 1998.
13. FELETOU M, VANHOUTTE PM: Endothelium dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93: 515-524, 1998.
14. FOLKOW B, GRIMBY G, THULESIUS O: Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 44: 255-272, 1958.
15. GARG UC, HASSID A: Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
16. GEROVÁ M, KRISTEK F: Efficiency of NO donors in substituting impaired endogenous NO production: a functional and morphological study. Physiol Res 50: 165-173, 2001.
17. GEROVÁ M, PECHÁŇOVÁ O, STOEV V, KITTOVÁ M, BERNÁTOVA I, JURÁNI M, DOLEŽEL S: Biomechanical signals in the coronary artery triggering the metabolic processes during cardiac overload. Mol Cell Biochem 147: 69-73, 1995.
18. GEROVÁ M, BERNÁTOVÁ I, HANÁČKOVÁ Y, JURÁNI M, TÖRÖK J: NO compromised hypertension of parents as reflected by offsprings. Physiol Res 49: 4P, 2000.
19. HEAGERTY AM, AALKJER C, BUND SJ, KORSGAGRD N, MULVANY MJ: Small artery structure in hypertension. Hypertension 21: 391-395, 1993.
20. KATO N, SUGIYAMA T, MORITA H, NABIKA T, KURIHARA H, YAMORI Y, YAZAKI Y: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33: 933-936, 1999.
21. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin reagent. J Biol Chem 193: 265-275, 1951.
22. MIYAMOTO Y, SAITO Y, KAJIYAMA N, YOSHIMURA M, SHIMASAKI Y, NAKAYAMA M, KAMITANI S, HARADA M, ISHIKAWA M, KUWAHARA K, OGAWA E, HAMANAKA I, TAKAHASHI N, KANESHIGE T, TERAOKA H, AKAMIZU T, AZUMA N, YOSHIMASA Y, ITOH H, MASUDA I, YASUE H, NAKAO K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8, 1998.
23. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, ŠIMKO F: Protein remodeling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29: 3365-3374, 1997.
24. PIGNATTI C, TANTINI B, STEFANELLI C, GIORDANO E, BONAVITA F, CLO C, CALDARERA CM: Nitric oxide mediated either proliferation or cell death in cardiomyocytes: involvement of polyamines. Amino Acids 6: 181-190, 1999.
25. PRICKAERTS J, DE VENTE J, MARKERINK-VAN ITTERSUM M, STEINBUSCH HWM: Behavioural, neurochemical and neuroanatomical effects of chronic postnatal N-nitro-L-arginine methyl ester treatment in neonatal and adult rats. Neuroscience 87: 181-195, 1998.
26. RADOMSKI MW, MARTIN JF, MONCADA S: Synthesis of nitric oxide by the haemocytes of the American horseshoe crab (Limulus polyphemus). Phil Trans R Soc Lond B 344: 129-133, 1991.
27. RIBEIRO MO, ANTUNES E, DE NUCCI G, LOVISOLO SM, ZATZ R: Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20: 298-303, 1992.
28. SHAUL PW, FARRAR MA, MAGNESS RR: Pulmonary endothelial nitric oxide production is developmentally regulated in the foetus and newborn. Am J Physiol 265: H1056-H1063, 1993.
29. SLÁDEK T, GEROVÁ M, ZNOJIL V, DEVÁT L: Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res 45: 335-338, 1996.
30. SLOTKIN TA, BARTOLOMÉ J: Ornithine decarboxylase: Marker of neuroendocrine and neurotransmitter action. In: Methods Enzymol 103: 590-603, 1983.
31. TADDEI S, VIRDIS A, MATTEI P, GHIADONI L, SUDANO I, SALVETTI A: Defective L-arginine-nitric oxide pathway in offsprings of essential hypertensive patients. Circulation 94: 1298-1303, 1996.
32. TÖRÖK J, GEROVÁ M: Vascular responses after long-term inhibition of nitric oxide synthesis in newborn dogs. Physiol Res 45: 323-328, 1996.
33. TÖRÖK J, GEROVÁ M: Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta. Mech Ageing Dev 95: 143-152, 1997.
34. TÖRÖK J, KRISTEK F: Pentaerythrityl tetranitrate attenuated functional and morphological changes in the rat thoracic aorta induced by long-term inhibition of nitric oxide synthase. Physiol Res 49: P17, 2000.
35. VOELKER CA, MILLER MD, ZHANG XS, ELOBY-CHILDRESS S, CLARK DA, PIERCE MR: Perinatal nitric oxide synthase inhibition retards neonatal growth by inducing hypertrophic pyloric stenosis in rats. Pediatr Res 38: 768-774, 1995.
36. ZIMMER HG, PEFFER H: Metabolic aspects of the development of experimental cardiac hypertrophy. In: Controversial Issues in Cardiac Pathophysiology. JACOB R (ed), Steinkopff Verlag, Darmstadt, 1986, pp 127-137.